We do know about the role of COVID-19 because COVID-19 only impacted who was speaking at NYAS and not the company’s decision to release the data by a 3rd party without any protection from a journal article and without any effort to help on the PR and IR side.
Dr. Liau is not well known enough to markets to have changed the basic criticisms especially given that officially the endpoints in the US had no changed yet, a fact critics took advantage of.
Market Data 
Markets 
AI
